
Innovative Study Design Alleviates Challenges Associated with Rare Disease Clinical Trials
The road to the approval of therapies for rare diseases is long and challenging. This blog post outlines how one study addresses this through embracing a multistakeholder approach, removing travel barriers associated with participation, and leveraging historical patient data to replace placebo data.